文献速递头颈技术与安全CT

原发性甲状旁腺功能亢进症中的甲状旁腺4D CT:探索用于识别多腺体病变和指导生化成功甲状旁腺切除术的尺寸测量

Parathyroid 4D CT in Primary Hyperparathyroidism: Exploration of Size Measurements for Identifying Multigland Disease and Guiding Biochemically Successful Parathyroidectomy.
PubMed 文献 · AJR Am J Roentgenol · 2021-12-22

回顾性纳入62例原发性甲状旁腺功能亢进症患者(单腺体病47例、多腺体病15例),评估甲状旁腺CT上高置信度候选病灶的估计体积和最大径对区分单腺体病与多腺体病及预测需切除腺体的价值;基于第二高置信度病灶,估计体积≥60 mm³诊断多腺体病的敏感度53%、特异度96%,最大径≥7 mm敏感度67%、特异度96%,4D-CT多腺体病评分≥3分敏感度47%、特异度68%;预测需切除腺体时,估计体积≥114 mm³敏感度84%、特异度97%,≥55 mm³敏感度93%、特异度87%,最大径≥7 mm敏感度93%、特异度84%。

要点

  • 第二高置信度病灶估计体积≥60 mm³或最大径≥7 mm对多腺体病特异度96%,敏感度分别为53%和67%。
  • 预测需切除腺体:估计体积≥114 mm³敏感度84%特异度97%,≥55 mm³敏感度93%特异度87%,最大径≥7 mm敏感度93%特异度84%。
  • 4D-CT多腺体病评分≥3分诊断多腺体病敏感度47%、特异度68%。

核心结论

  • 高置信度候选病灶的估计体积和最大径可区分单腺体病与多腺体病,并识别为生化成功甲状旁腺切除术需切除的单个腺体;同时考虑第一和第二高置信度病灶可能有助于区分单腺体病与多腺体病。

研究设计与样本

  • 回顾性研究纳入62例原发性甲状旁腺功能亢进症患者(女41例、男21例,中位年龄65岁),均于术前甲状旁腺CT后接受生化成功甲状旁腺切除术,其中单腺体病47例、多腺体病15例,共151个候选病灶含106个高置信度病灶。

关键影像表现/征象

  • 临床影像报告将候选甲状旁腺病灶分为低、中、高置信度病灶,切除的高细胞甲状旁腺病灶与临床报告的候选病灶进行关联。
  • 患者依据手术和病理报告独立于CT表现分类为单腺体病或多腺体病。
  • 一名观察者回顾性测定临床报告的高置信度病灶的估计体积(0.52×长×宽×高)和最大径,并计算检查的4D-CT多腺体病评分。

诊断标准与关键数值

  • 基于第二高置信度病灶区分多腺体病:估计体积≥60 mm³敏感度53%、特异度96%;最大径≥7 mm敏感度67%、特异度96%。
  • 4D-CT多腺体病评分≥3分诊断多腺体病敏感度47%、特异度68%。
  • 预测为生化成功甲状旁腺切除术需切除腺体:估计体积≥114 mm³敏感度84%、特异度97%;估计体积≥55 mm³敏感度93%、特异度87%;最大径≥7 mm敏感度93%、特异度84%。

临床应用与阅片要点

  • 术前甲状旁腺CT上高置信度候选病灶的估计体积和最大径可用于辅助区分单腺体病与多腺体病。
  • 同时考虑第一和第二高置信度病灶的尺寸可能有助于区分单腺体病与多腺体病。
  • 高置信度候选病灶的尺寸测量有助于识别可能需双侧颈部探查的患者,为术前患者咨询和个体化手术规划提供信息。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND. In patients with primary hyperparathyroidism (PHPT), bilateral neck exploration is necessary for multigland disease (MGD), whereas minimally invasive parathyroidectomy is often preferred for single-gland disease (SGD). An existing system (the 4D-CT MGD score) for differentiating SGD from MGD with the use of preoperative parathyroid CT considers the size of only the largest candidate lesion. OBJECTIVE. The purpose of this study was to assess the utility of the size of the second-largest lesion on parathyroid CT for differentiating SGD from MGD as well as the utility of individual gland size for predicting the need for surgical removal and to derive optimal size thresholds for these purposes. METHODS. This retrospective study included patients with PHPT who underwent biochemically successful parathyroidectomy after preoperative parathyroid CT. Clinical radiology reports were reviewed to classify reported candidate parathyroid lesions as low-, intermediate-, or high-confidence lesions. Resected hypercellular parathyroid lesions were correlated with clinically reported candidate lesions. Patients were classified as having SGD or MGD on the basis of operative and pathology reports, independent of CT findings. One observer retrospectively determined the estimated volume (0.52 × length × width × height) and maximum diameter of clinically reported high-confidence lesions, as well as the 4D-CT MGD scores from the examinations. Diagnostic performance was assessed. RESULTS. The sample comprised 62 patients (41 women, 21 men; median age, 65 years), 47 of whom had SGD and 15 of whom had MGD, with 151 candidate lesions, including 106 high-confidence lesions. Based on the second-largest high-confidence lesions, an estimated volume threshold of 60 mm3 or greater achieved 53% sensitivity and 96% specificity, whereas a maximum diameter threshold of 7 mm or greater achieved 67% sensitivity and 96% specificity for MGD; a 4D-CT MGD score of 3 or greater achieved 47% sensitivity and 68% specificity for MGD. For predicting the need to remove a gland for successful parathyroidectomy, an estimated volume threshold of 114 mm3 or greater achieved 84% sensitivity and 97% specificity, and a threshold of 55 mm3 or greater achieved 93% sensitivity and 87% specificity; a maximum diameter threshold of 7 mm or greater achieved 93% sensitivity and 84% specificity. CONCLUSION. The estimated volume and maximum diameter of high-confidence candidate lesions can differentiate SGD from MGD and identify individual glands requiring removal for successful parathyroidectomy. Differentiating SGD from MGD may be aided by considering both the first- and second-largest high-confidence lesions. CLINICAL IMPACT. The findings will help identify patients who are likely to require bilateral neck explorations, informing preoperative patient counseling and individualized operative planning.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Bunch, Goyal, Valenzuela, et al. Parathyroid 4D CT in Primary Hyperparathyroidism: Exploration of Size Measurements for Identifying Multigland Disease and Guiding Biochemically Successful Parathyroidectomy. AJR Am J Roentgenol. 2021. PMID: 34935402. doi:10.2214/AJR.21.26935

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。